MRS Logística S.A.

BOVESPA:MRSA3B Stock Report

Market Cap: R$9.7b

MRS Logística Future Growth

Future criteria checks 0/6

We currently don't have sufficient analyst coverage to forecast growth and revenue for MRS Logística.

Key information

n/a

Earnings growth rate

n/a

EPS growth rate

Transportation earnings growth49.7%
Revenue growth raten/a
Future return on equityn/a
Analyst coverage

None

Last updatedn/a

Recent future growth updates

No updates

Recent updates

Is MRS Logística (BVMF:MRSA3B) Using Too Much Debt?

Sep 30
Is MRS Logística (BVMF:MRSA3B) Using Too Much Debt?

MRS Logística (BVMF:MRSA3B) Might Have The Makings Of A Multi-Bagger

Jul 22
MRS Logística (BVMF:MRSA3B) Might Have The Makings Of A Multi-Bagger

Investors Continue Waiting On Sidelines For MRS Logística S.A. (BVMF:MRSA3B)

Jun 26
Investors Continue Waiting On Sidelines For MRS Logística S.A. (BVMF:MRSA3B)

These 4 Measures Indicate That MRS Logística (BVMF:MRSA3B) Is Using Debt Reasonably Well

May 28
These 4 Measures Indicate That MRS Logística (BVMF:MRSA3B) Is Using Debt Reasonably Well

MRS Logística S.A. (BVMF:MRSA3B) Screens Well But There Might Be A Catch

Mar 06
MRS Logística S.A. (BVMF:MRSA3B) Screens Well But There Might Be A Catch

We Think MRS Logística (BVMF:MRSA3B) Can Stay On Top Of Its Debt

Feb 05
We Think MRS Logística (BVMF:MRSA3B) Can Stay On Top Of Its Debt

In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as MRS Logística has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.

Earnings and Revenue Growth Forecasts

BOVESPA:MRSA3B - Analysts future estimates and past financials data (BRL Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
6/30/20247,0701,3891,0683,200N/A
3/31/20246,8481,3701,3393,404N/A
12/31/20236,4491,2001,6783,622N/A
9/30/20236,1291,1501,3272,920N/A
6/30/20235,9211,0488012,638N/A
3/31/20235,7389204932,303N/A
12/31/20225,592874341,872N/A
9/30/20225,1906961071,920N/A
6/30/20224,843511-2061,606N/A
3/31/20224,562725-721,575N/A
12/31/20214,427700531,571N/A
9/30/20214,3468605641,881N/A
6/30/20214,1308719331,919N/A
3/31/20213,8955978791,732N/A
12/31/20203,6054301,1802,002N/A
9/30/20203,3162918661,522N/A
6/30/20203,1613239921,591N/A
3/31/20203,0482967701,404N/A
12/31/20193,2015034471,106N/A
9/30/20193,4925615341,181N/A
6/30/20193,6375445611,161N/A
3/31/20193,7335496081,298N/A
12/31/20183,7265224361,136N/A
9/30/20183,6384453771,193N/A
6/30/20183,5334263181,081N/A
3/31/20183,515446N/A1,112N/A
12/31/20173,493461N/A1,040N/A
9/30/20173,399447N/A1,059N/A
6/30/20173,390416N/A1,028N/A
3/31/20173,329357N/A1,020N/A
12/31/20163,279418N/A966N/A
9/30/20163,355456N/A1,003N/A
6/30/20163,269398N/A958N/A
3/31/20163,202405N/A869N/A
12/31/20153,173296N/A1,092N/A
9/30/20153,134337N/A1,024N/A
6/30/20153,122353N/A1,006N/A
3/31/20153,113362N/A1,059N/A
12/31/20143,063379N/A988N/A
9/30/20143,060399N/A988N/A
6/30/20143,085482N/A945N/A
3/31/20143,078479N/A1,024N/A
12/31/20133,038469N/A1,023N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: Insufficient data to determine if MRSA3B's forecast earnings growth is above the savings rate (10.1%).

Earnings vs Market: Insufficient data to determine if MRSA3B's earnings are forecast to grow faster than the BR market

High Growth Earnings: Insufficient data to determine if MRSA3B's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: Insufficient data to determine if MRSA3B's revenue is forecast to grow faster than the BR market.

High Growth Revenue: Insufficient data to determine if MRSA3B's revenue is forecast to grow faster than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: Insufficient data to determine if MRSA3B's Return on Equity is forecast to be high in 3 years time

Discover growth companies

7D

1Y

7D

1Y

7D

1Y